{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:16:45Z","timestamp":1763749005905,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the relation between interleukin-6 concentration and oxidative status of HIV infected patients with or at risk of Kaposi\u2019s disease in Yaound\u00e9.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a two-months cross-sectional study on 87 consenting HIV infected patients followed at the Day Hospital of the Yaound\u00e9 Central Hospital. Serum\/plasma obtained after centrifugation of blood collected in dry\/EDTA tubes was used for the determination of Human Herpes Virus-8 antigen (HHV-8) and Interleukin-6 (IL-6) by the ELISA technique, and that of oxidative stress markers: Malondialdehyde (MDA) reduced Glutathione (GSH) and total antioxidant capacity by spectrophotometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Subjects belonging to the [40\u201350[year-old age group were mainly represented in our study population with 43.7%. The average age was 44.6\u2009\u00b1\u200910.4 years with extremes ranging from 26 to 72 years. The sex ratio was 0.24. Our population was mainly represented by people infected with HIV type I (90.8%) and 3.4% had developed clinical signs of Kaposi\u2019s disease. The prevalence of the HHV-8 antigen was 57.5%. Immune and oxidative parameters did not vary with age, sex and therapeutic line. We noted a significant increase in IL-6 concentrations in patients positive to the HHV-8 antigen for IL-6 concentrations\u2009&lt;\u200937 (P\u2009=\u20090.005; CI= [0.40; 0.59]. MDA and GSH concentrations increased significantly with the HHV-8 infection (P\u2009&lt;\u20090.0001; CI= [0.40; 0.59] and P\u2009&lt;\u20090.0001; CI= [13.30;21.45], respectively). Total antioxidant capacity (FRAP) decreased significantly with HHV-8 infection (P\u2009=\u20090.004; CI= [-69.18; -13.78]). We noted a significant increase in MDA concentrations in patients taking their ARVs irregularly, (P\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study showed a weak positive correlation between IL-6 and MDA, a strong negative correlation between FRAP and MDA and a strong positive correlation between MDA and GSH highlighting the association of these few markers of oxidative stress and Il-6 to the risk of Kaposi\u2019s disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-023-02109-9","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T14:02:30Z","timestamp":1690293750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with \/or at risk of Kaposi disease in Yaounde"],"prefix":"10.1186","volume":"20","author":[{"given":"Roger Ahouga","family":"Voufo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand Emmanuel","family":"Kouotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nchinda Jones","family":"Tatah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"TeTo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Gueguim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal Marie Essome","family":"Ngond\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand Gabin","family":"Njiguet Tepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Gabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falmata","family":"Amazia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha Lena","family":"Yembeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kouanfack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-6494","authenticated-orcid":false,"given":"Pieme Constant","family":"Anatole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"issue":"2","key":"2109_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","volume":"137","author":"O Radu","year":"2013","unstructured":"Radu O, Pantanowitz L. Kaposi Sarcoma. Arch Pathol Lab Mesd 31 janv. 2013;137(2):289\u201394.","journal-title":"Arch Pathol Lab Mesd 31 janv"},{"issue":"4","key":"2109_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40257-017-0270-4","volume":"18","author":"JW Schneider","year":"2017","unstructured":"Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi Sarcoma. Am J Clin Dermatol ao\u00fbt. 2017;18(4):529\u201339.","journal-title":"Am J Clin Dermatol ao\u00fbt"},{"issue":"5","key":"2109_CR3","first-page":"393","volume":"90","author":"F Bou\u00e9","year":"2003","unstructured":"Bou\u00e9 F, Lebb\u00e9 C. Le sarcome de Kaposi. Bull Cancer (Paris). 2003;90(5):393\u20138.","journal-title":"Bull Cancer (Paris)"},{"key":"2109_CR4","unstructured":"Aubry PP. Maladie de Kaposi Actualit\u00e9s 2019.:5."},{"key":"2109_CR5","unstructured":"NDOUMA AG. Maladie de Kaposi stomatologique chez les personnes vivant avec le VIH\/Sida:\u00e9tude de 12 cas observ\u00e9s \u00e0 Yaound\u00e9 [Internet]. HEALTH SCIENCES AND DISEASE. ; 2014 [cit\u00e9 19 mai 2020]. Disponible sur: https:\/\/www.hsd-fmsb.org\/index.php\/hsd\/thesis\/view\/192"},{"key":"2109_CR6","doi-asserted-by":"publisher","first-page":"1521020","DOI":"10.1155\/2017\/1521020","volume":"2017","author":"D Cappetta","year":"2017","unstructured":"Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, et al. Oxidative stress and Cellular Response to Doxorubicin: a common factor in the Complex Milieu of Anthracycline Cardiotoxicity. Oxid Med Cell Longev. 2017;2017:1521020.","journal-title":"Oxid Med Cell Longev"},{"key":"2109_CR7","doi-asserted-by":"crossref","unstructured":"Yan L, Majerciak V, Zheng Z-M, Lan K. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis. Virol Sin. avr 2019;34(2):135\u201361.","DOI":"10.1007\/s12250-019-00114-3"},{"issue":"11","key":"2109_CR8","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1039\/C7MB00336F","volume":"13","author":"AA Williams","year":"2017","unstructured":"Williams AA, Sitole LJ, Meyer D. HIV\/HAART-associated oxidative stress is detectable by metabonomics. Mol Biosyst 24 oct. 2017;13(11):2202\u201317.","journal-title":"Mol Biosyst 24 oct"},{"key":"2109_CR9","doi-asserted-by":"publisher","first-page":"8910396","DOI":"10.1155\/2016\/8910396","volume":"2016","author":"AV Ivanov","year":"2016","unstructured":"Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, et al. Oxidative stress during HIV infection: mechanisms and consequences. Oxid Med Cell Longev. 2016;2016:8910396.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2109_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41435-019-0077-9","volume":"20","author":"EM Cornejo Castro","year":"2019","unstructured":"Cornejo Castro EM, Morrison BJ, Marshall VA, Labo N, Miley WJ, Clements N, et al. Relationship between human leukocyte antigen alleles and risk of Kaposi\u2019s sarcoma in Cameroon. Genes Immun. 2019;20(8):684\u20139.","journal-title":"Genes Immun"},{"key":"2109_CR11","unstructured":"Bikoi JN, Ndom P, Ikomey G, Demanou GA, Mupang L, Etoa FX. R\u00e9ponse Immunitaire chez les Malades Porteurs d\u2019un Sarcome de Kaposi \u00e0 l\u2019H\u00f4pital G\u00e9n\u00e9ral de Yaound\u00e9. Health Sci Dis [Internet] 17 ao\u00fbt 2015 [cit\u00e9 19 mai 2020];16(3). Disponible sur: http:\/\/hsd-fmsb.org\/index.php\/hsd\/article\/view\/508"},{"key":"2109_CR12","doi-asserted-by":"crossref","unstructured":"Jacky NB, Paul N, Lilian M, Sylvie AD. S\u00e9ropr\u00e9valence du virus de l\u2019herp\u00e8s humain-8 chez des patients VIH positif \u00e0 l\u2019h\u00f4pital g\u00e9n\u00e9ral de Yaound\u00e9 \u2013 Cameroun. Pan Afr Med J [Internet] 26 janv 2015 [cit\u00e9 19 mai 2020];20. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4450027\/","DOI":"10.11604\/pamj.2015.20.69.5671"},{"key":"2109_CR13","unstructured":"HHV-8 elisa. kit | Human Herpes virus 8 (HHV-8) ELISA Kit [Internet]. [cit\u00e9 3 janv 2021]. Disponible sur: https:\/\/www.mybiosource.com\/human-elisa-kits\/herpes-virus-8-hhv-8\/167838"},{"issue":"1","key":"2109_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0022-1759(91)90063-L","volume":"138","author":"M Helle","year":"1991","unstructured":"Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 8 avr. 1991;138(1):47\u201356.","journal-title":"J Immunol Methods 8 avr"},{"issue":"2","key":"2109_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0006-2944(76)90049-1","volume":"15","author":"K Yagi","year":"1976","unstructured":"Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med avr. 1976;15(2):212\u20136.","journal-title":"Biochem Med avr"},{"issue":"1","key":"2109_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of \u00ab antioxidant power \u00bb: the FRAP assay. Anal Biochem 15 juill. 1996;239(1):70\u20136.","journal-title":"Anal Biochem 15 juill"},{"issue":"1","key":"2109_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys mai. 1959;82(1):70\u20137.","journal-title":"Arch Biochem Biophys mai"},{"key":"2109_CR18","unstructured":"Sida. on conna\u00eet d\u00e9sormais l\u2019origine des quatre souches du virus [Internet]. Sciences et Avenir. [cit\u00e9 16 f\u00e9vr 2021]. Disponible sur: https:\/\/www.sciencesetavenir.fr\/sante\/sida-on-connait-desormais-l-origine-des-quatre-souches-du-virus_28661"},{"issue":"9","key":"2109_CR19","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3390\/v5092253","volume":"5","author":"C Mbondji-Wonje","year":"2013","unstructured":"Mbondji-Wonje C, Ragupathy V, Lee S, Wood O, Awazi B, Hewlett IK. Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon. Viruses 19 sept. 2013;5(9):2253\u20139.","journal-title":"Viruses 19 sept"},{"key":"2109_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2017.04.018","volume":"20","author":"E Fuentes-Mattei","year":"2017","unstructured":"Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, et al. Plasma viral miRNAs indicate a high prevalence of Occult viral infections. EBioMedicine juin. 2017;20:182\u201392.","journal-title":"EBioMedicine juin"},{"key":"2109_CR21","unstructured":"Taieb F. Acc\u00e8s \u00e0 la charge virale pour les patients infect\u00e9s par le VIH sous traitement antiretrovirn zone d\u00e9centralis\u00e9e des pays \u00e0 niveau de ressources faible ou mod\u00e9r\u00e9.:139."},{"key":"2109_CR22","unstructured":"HIV ET CYTOKINES [Internet]. [cit\u00e9 28 janv 2021]. Disponible sur: http:\/\/www.positifs.org\/old\/c\/c-38.htm"},{"issue":"10","key":"2109_CR23","first-page":"875","volume":"26","author":"N Thorin-Trescases","year":"2010","unstructured":"Thorin-Trescases N, Voghel G, Farhat N, Drouin A, Gendron M-\u00c8, Thorin \u00c9. \u00c2ge et stress oxydant: vers un d\u00e9s\u00e9quilibre irr\u00e9versible de l\u2019hom\u00e9ostasie endoth\u00e9liale. Med Sci MS oct. 2010;26(10):875\u201380.","journal-title":"Med Sci MS oct"},{"key":"2109_CR24","first-page":"135","volume":"25","author":"I Gammoudi","year":"2010","unstructured":"Gammoudi I, Khelil S, Dandana A, Jaidane Z, Chalghoum A, Noichri Y, et al. \u00c9tude des marqueurs du stress oxydatif chez les coronariens tabagiques tunisiens. Immuno-Anal Biol Spec - IMMUNO-ANAL BIOL SPEC. 1 juin. 2010;25:135\u20139.","journal-title":"1 juin"},{"key":"2109_CR25","unstructured":"Martinez V. Virus herp\u00e8s humain 8 et maladie de Kaposi au cours de l\u2019infection par le VIH : interactions et impact des traitements antir\u00e9troviraux - Human herpesvirus 8 and AIDS-associated Kaposi\u2019s sarcoma: interaction and impact of antiretroviral therapy. Volume 5. M ISE AU POINT; 2005."},{"key":"2109_CR26","unstructured":"\u00c9ric KI, Michel BE, David MK, Athy KK, Julien IN, Anzwal L et al. Stress oxydatif et dommage sur le DNA au cours de l\u2019infection \u00e0 VIH, R\u00f4le du Yaourt Probiotique dans la pr\u00e9vention.:6."},{"key":"2109_CR27","doi-asserted-by":"crossref","unstructured":"Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN, Takou D et al. Lipid Peroxidation and Total Cholesterol in HAART-Na\u00efve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon. PLOS ONE. 7 juin 2013;8(6):e65126.","DOI":"10.1371\/journal.pone.0065126"},{"issue":"11\u201312","key":"2109_CR28","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.nut.2016.03.024","volume":"32","author":"LM Watanabe","year":"2016","unstructured":"Watanabe LM, Barbosa J\u00fanior F, Jord\u00e3o AA, Navarro AM. Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidant protection. Nutr Burbank Los Angel Cty Calif d\u00e9c. 2016;32(11\u201312):1238\u201342.","journal-title":"Nutr Burbank Los Angel Cty Calif d\u00e9c"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02109-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-02109-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02109-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T14:03:22Z","timestamp":1690293802000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-02109-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-02109-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the Faculty of Medicine and Biomedical Sciences of the University of Yaound\u00e9 I (Institutional Committee on Research Ethics) (No 295\/UYI\/FMSB\/VDRC\/DAASR\/CSD) and the Regional Committee on Ethics in Human Health Research of the Cameroun (CE1567 CRERSHC\/2020)) Centre as well as administrative authorizations of the sample collection and analysis structures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}